-
venBio is a life sciences investment firm that partners with industry leaders to build game-changing medicines and technologies, with a focus on novel therapeutics for unmet medical needs.
Latest News
-
2018
25JUNAkero Therapeutics Closes $65 Million Series A Financing to Advance New Treatments for Serious Metabolic Diseases
posted by admin in Latest NewsFinancing led by Apple Tree Partners, Atlas Venture, venBio Partners and Versant Ventures.
Read More -
2017
17APRTLR9 Agonist CMP-001-Pembrolizumab Combination Shows Early Efficacy in Patients With Metastatic Melanoma Resistant to Anti-PD-1
posted by admin in Latest NewsA combination of CMP-001, an intratumoral Toll-like receptor 9 (TLR9) agonist...
Read More -
2018
24JANMenlo Therapeutics Inc. Announces Pricing of Initial Public Offering of Common Stock
posted by admin in Latest NewsMenlo Therapeutics Inc. (NASDAQ:MNLO) today announced the pricing of the Company's initial public offering of 7,000,000 shares of common stock at a public offering price of $17.00 per share, before underwriting discounts.
Read More -
2018
04JANNeurogastrx, Inc. Raises $45M Series A To Bring Lead GI Candidate Through Proof Of Concept
posted by admin in Latest NewsNeurogastrx, Inc. Raises $45M Series A To Bring Lead GI Candidate Through Proof Of Concept
Read More